FDA Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of FDA Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bird Flu
Encorium Group Awarded $1.2 Million Contract for Study of a New Vaccine for Seasonal and Pandemic Avian Influenza
March 15th, 2007
Encorium Group, Inc. (Nasdaq: ENCO), a leader in the design, development, and management of complex clinical trials and patient registries for many of the world's leading pharmaceutical and biotechnology companies, announced the awarding of a Phase 1 contract having a value of approximately $1.2 million. This contract is in support of an innovative approach to the development of a vaccine for the prevention of multiple types of influenza including Seasonal and Pandemic Avian Flu. Services include consulting on clinical trial design and protocol development, project and study site management and monitoring, data management, and biostatistical support. Revenue recognition will begin in the...
Source: FDA Law Weekly (2007-03-15)
|
